Protective Mechanisms of CO in Intestinal Inflammation
CO对肠道炎症的保护机制
基本信息
- 批准号:7467952
- 负责人:
- 金额:$ 28.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AbdomenAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsAttentionAttenuatedBilirubinBiliverdineCarbon MonoxideCatabolismClinicalClinical ManagementColonConditionDevelopmentDisruptionEnteralEnzymesEventExhibitsExperimental ModelsExposure toFerritinFigs - dietaryGastrointestinal MotilityGastrointestinal tract structureGenetic TranscriptionGenus ColaGraft SurvivalHemeIleusIn VitroInflammationInflammatoryInflammatory disease of the intestineInhalation ExposureInjuryIntestinesInvasiveIronLength of StayLiteratureLiverLungMeasuresMediatingMediator of activation proteinMolecularMusMuscleOperative Surgical ProceduresOrganOrgan TransplantationOxidative StressOxygenasesPan GenusPathway interactionsPostoperative PeriodPropertyProtein IsoformsProteinsPublishingRateReperfusion InjuryReportingResearch PersonnelResolutionRodent ModelRoleSignal TransductionSignal Transduction PathwaySiteSmall IntestinesStressTechniquesTestingTissuesTranslationsactivating transcription factorbiological adaptation to stressbody systemclinically relevantenzyme activitygastrointestinalheme oxygenase-1improvedin vivoinsightinterestlung injurymedical complicationmotility disordermutantnovelpreventprogramsprotective effectregional differenceresponserestorationtool
项目摘要
DESCRIPTION (provided by applicant): Postoperative ileus, the impaired intestinal contractility following abdominal surgery, continues to be a major clinical problem, extending hospital stay and contributing to medical complications. We and others have observed that operative procedures initiate pro-inflammatory molecular events within the muscle layer of the G.I. tract which underlie the development of intestinal dysmotility. Furthermore, differences in the onset and resolution of inflammation have been identified in the small bowel and colon. The role of anti-inflammatory mechanisms in the resolution of inflammation and restoration of function are still ill-defined. We hypothesize that the early induction of anti-inflammatory pathways, or providing the endproducts of these pathways, could be exploited therapeutically to limit inflammation and reduce or prevent the functional and molecular manifestations of postoperative ileus. The inducible isoform of the enzyme heme oxygenase, HO-1, is a ubiquitous stress response protein that is highly induced by a variety of stress-related conditions. Studies report that early induction of HO-1, or exposure by inhalation to very low concentrations of CO, a normal byproduct of HO-1 activity, is highly protective against inflammatory injury. The proposed studies will establish signaling mechanisms by which CO-induced anti-inflammatory pathways protect the gut from the functional and molecular manifestations of inflammation. CO exposure constitutes a novel and non-invasive technique to determine how regional differences in pro- and anti-inflammatory signaling events are regulated, findings that have important implications for clinical management strategies, not just for intestinal inflammation, but also other organ systems. Specific aims: AIM 1: Determine whether exposure to CO prior to colonic surgery will attenuate colonic dysmotility. AIM 2: Determine effects of CO exposure on pro- and anti-inflammatory mediator expression (transcription, translation, enzyme activity) in the colon. AIM 3: Identify the mechanistic pathways by which CO alters pro- and anti-inflammatory signaling, and identify regional differences.
描述(由申请方提供):术后肠梗阻,即腹部手术后肠收缩力受损,仍然是一个主要的临床问题,延长了住院时间并导致医疗并发症。我们和其他人已经观察到,手术程序在胃肠道肌肉层内启动促炎分子事件。肠道运动障碍的基础发展。此外,已经在小肠和结肠中确定了炎症发作和消退的差异。抗炎机制在炎症消退和功能恢复中的作用仍然不明确。我们假设,抗炎通路的早期诱导,或提供这些通路的终产物,可以在治疗上用于限制炎症,减少或预防术后肠梗阻的功能和分子表现。血红素加氧酶HO-1的诱导型同工型是一种普遍存在的应激反应蛋白,其由多种应激相关条件高度诱导。研究报告称,HO-1的早期诱导,或通过吸入非常低浓度的CO(HO-1活性的正常副产物),对炎症损伤具有高度保护作用。拟议的研究将建立信号传导机制,通过该机制,CO诱导的抗炎途径保护肠道免受炎症的功能和分子表现的影响。CO暴露构成了一种新的非侵入性技术,以确定促炎和抗炎信号传导事件的区域差异如何调节,这些发现对临床管理策略具有重要意义,不仅适用于肠道炎症,而且适用于其他器官系统。具体目的:目的1:确定结肠手术前暴露于CO是否会减轻结肠动力障碍。目的2:确定CO暴露对结肠中促炎和抗炎介质表达(转录,翻译,酶活性)的影响。目的3:确定CO改变促炎和抗炎信号传导的机制途径,并确定区域差异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANTHONY J BAUER其他文献
ANTHONY J BAUER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANTHONY J BAUER', 18)}}的其他基金
Protective Mechanisms of CO in Intestinal Inflammation
CO对肠道炎症的保护机制
- 批准号:
7263899 - 财政年份:2005
- 资助金额:
$ 28.17万 - 项目类别:
Protective Mechanisms of CO in Intestinal Inflammation
CO对肠道炎症的保护机制
- 批准号:
7089013 - 财政年份:2005
- 资助金额:
$ 28.17万 - 项目类别:
Protective Mechanisms of CO in Intestinal Inflammation
CO对肠道炎症的保护机制
- 批准号:
7646299 - 财政年份:2005
- 资助金额:
$ 28.17万 - 项目类别:
Protective Mechanisms of CO in Intestinal Inflammation
CO对肠道炎症的保护机制
- 批准号:
6923425 - 财政年份:2005
- 资助金额:
$ 28.17万 - 项目类别:
INTESTINAL INFLAMMATORY SYNERGY BETWEEN HEMORRHAGIC SHOCK AND TRAUMA
失血性休克和创伤之间的肠道炎症协同作用
- 批准号:
6829218 - 财政年份:2004
- 资助金额:
$ 28.17万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 28.17万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 28.17万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 28.17万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 28.17万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 28.17万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 28.17万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 28.17万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 28.17万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 28.17万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 28.17万 - 项目类别: